In particular, while the first two reports lead to opposite conclusions, probably due to different cellular context, the last report confirmed that BCR-ABL interacts with CK2α in CML cells and that this interaction promotes cellular proliferation. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.